Medidata eCOA vs WeGuide(eCOA)

Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial.

Scope Electronic clinical outcome assessment (eCOA) platforms that capture patient-reported (ePRO), clinician-reported, observer-reported and performance outcomes in regulated clinical trials, as a sponsor, CRO or academic research team would shortlist them.

Guide updated How we compare

Compare within eCOA

Study fit, side by side

These notes describe the products in the eCOA guide.

Medidata eCOA

Best for
Large sponsors and CROs that already run Rave EDC and want eCOA in the same platform
What to consider
Medidata eCOA lists 2,500+ COAs, 200+ languages and dialects and 1,600+ studies, and data flows straight into Rave EDC. Study builders can configure it in Medidata Designer, with an average study start of 8 weeks. Prices are not published.
Read product profile

WeGuide

Best for
Clinical trials and research studies where ongoing participant engagement is central, with electronic assessments, reminders and follow-up in one study app
What to consider
WeGuide combines electronic outcome assessments with ongoing participant engagement for clinical trials and research studies. Teams connect assessments with consent, reminders and follow-up in a branded study app, with multilingual and wearable-data options. This supports study designs that need participants to stay involved between visits or over time, including investigator-led studies, cohorts and registries. Suitability depends on the assessments and workflows required, rather than study size alone. Confirm instrument licensing, assessment validation and any intensive site-entry or device-logistics needs.
Less suitable for
Protocols requiring a fully managed global provisioned-device fleet or an enterprise EDC and drug-supply suite from the same provider; confirm the required capture modes and services.

Study-fit source

Read product profile

Compare the features

Both products use the same category definitions. Product order is editorial; products are not ranked.

Full eCOA feature comparison

Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.

Expand a feature definition or support note for context and its original source.

Medidata eCOA vs WeGuide (eCOA): category feature evidence and sources. Products are not ranked.
Category featureMedidata eCOAWeGuide
Validated instrument library and licensing
Feature definitions
Supported
A library of outcome-assessment instruments is documented.
Extended support
A validated or instrument-author-approved library plus managed instrument licensing are documented.
Extended support

2,500+ COAs and a global instrument library for reusing builds and translations; Medidata also offers a validated instrument license management service.

Source
About this support label

A reusable instrument library is paired with a validated instrument license-management service.

Supported

WeGuide publishes an assessment-instrument library and describes instrument licensing and digital-migration support. Confirm permissions and validation responsibilities for each chosen instrument.

Source
About this support label

Outcome forms and licensing support are described; confirm author approval and the managed licensing scope for each selected instrument before assuming the extended definition is met.

Regulatory compliance and track record
Feature definitions
Supported
Relevant trial or security controls are stated.
Extended support
Relevant trial controls plus a public ISO/SOC certificate or audit report are documented; a certification claim or logo alone is insufficient.
Supported

Medidata says its AI functionality supports 80% of 2025 FDA novel drug approvals (company-wide platform claim, not eCOA alone); position statements on Part 11, Annex 11 and ICH E6 are published.

Source
About this support label

Part 11, Annex 11 and ICH E6 statements are documented; the approval claim is company-wide.

Supported

WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report.

Source
About this support label

Public statements establish the documented-support level; no public certificate or audit report establishes extended support.

Global scale and languages
Feature definitions
Supported
Multicountry use or multilingual/localized participant support is documented.
Extended support
Both multicountry use and multilingual/localized participant support are documented.
Supported

200+ languages and dialects, 1,600+ eCOA studies, 90K+ sites and 460+ sponsors.

Source
About this support label

Languages and study volumes are documented; this note does not establish multicountry use.

Extended support

WeGuide describes BRACE across five countries and INHERIT in ten languages. These are examples of participant outcome collection, rather than a claim of enterprise-scale eCOA deployment.

Source
About this support label

Published multicountry research and multilingual participant workflows meet the shared definition.

Capture modes and integrations
Feature definitions
Supported
Electronic outcome capture and a connection to another trial system or device are documented.
Extended support
Capture on participant-owned and provisioned devices plus wearable or sensor integration are documented.
Supported

BYOD (iOS, Android), provisioned devices and web; data flows into Rave EDC; Sensor Cloud is listed among Patient Cloud applications.

Source
About this support label

BYOD, provisioned devices and Rave data flow are documented; listing Sensor Cloud does not establish sensor integration.

Supported

Electronic participant outcome forms connect to existing EDC systems through the Integration Engine. Provisioned-device fleet delivery is not established by this source.

Source
About this support label

Electronic capture and system connections are documented; the source does not establish provisioned-device fleet support.

Time to launch and self-service build
Feature definitions
Supported
A study build process, self-service builder or launch timeframe is documented.
Extended support
Study teams can configure the study themselves, with a stated build or launch timeframe.
Extended support

Medidata Designer lets study builders configure questionnaires with drag-and-drop templates; average study start 8 weeks versus a 12-week industry standard.

Source
About this support label

Study builders configure questionnaires in Designer, with an average eight-week study start.

Extended support

The no-code study builder supports team configuration; WeGuide states a typical two-to-four-week configuration period with implementation support.

Source
About this support label

Team-configurable study workflows and a stated configuration timeframe meet the same launch definition applied to other products.

Published pricing and terms
Feature definitions
Supported
A production pricing basis, model or contract terms beyond a sales contact are published.
Extended support
Numerical production prices or a free production option with its conditions are published.
Supported

No prices published; Medidata's public Patient Cloud service descriptions set out contract terms, such as devices provisioned on a rental basis, caps on fee adjustments and early-termination fees.

Source
Supported

WeGuide publishes a per-study quote basis. Contact the team for a study-specific quote; numerical prices are not published.

Source

The guide update date reflects guide edits. Vendor statements are attributed in the evidence.

Keep the category in view

Compare these products with the other tools in the eCOA guide using the same feature definitions.

More eCOA comparisons featuring one of these products.